Endothelin-1 axis as a therapeutic target in oral squamous cell carcinoma: Molecular insights - 07/02/24
Doi : 10.1016/j.jormas.2024.101792
Jayanthi Pazhani a, Selvaraj Jayaraman a, ⁎ 
, Vishnu Priya Veeraraghavan a, Sharmila Jasmine b
, Vishnu Priya Veeraraghavan a, Sharmila Jasmine b a Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical & Technical Sciences, Saveetha University, Chennai, 600 077, India
b Department of Oral Maxillofacial Surgery, Rajas Dental College and Hospital, Kavalkinaru, Tirunelveli, 627105, Tamil Nadu, India
⁎Corresponding author at: Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical & Technical Sciences, Chennai, Tamil Nadu 600 077, India.Centre of Molecular Medicine and Diagnostics (COMManD)Department of BiochemistrySaveetha Dental College & HospitalsSaveetha Institute of Medical & Technical SciencesChennaiTamil Nadu600 077India
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
© 2024
Elsevier Masson SAS. Tous droits réservés.
Vol 125 - N° 6
Article 101792- décembre 2024 Retour au numéro
Article suivant
- Reconstruction of the orbitozygomatic framework: State of the art and perspectives
- Ségolène Reiss, Dimitri Kulker, Boris Laure, Arnaud Paré
Bienvenue sur EM-consulte, la référence des professionnels de santé.